CHERYL PORTA: Open Payments
NPI 1891158408 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 36 payments from 11 companies in 2025. Trend: 2023 $1,054 · 2024 $1,100 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $137 |
| ABBVIE INC. | 7 | $121 |
| PFIZER INC. | 6 | $113 |
| MDD US Operations, LLC | 4 | $72 |
| Lilly USA, LLC | 3 | $50 |
| Neurelis, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $18 |
| Otter Pharmaceuticals, LLC | 1 | $17 |
| SK Life Science, Inc. | 1 | $17 |
Products named: NURTEC ODT, Nayzilam, KISUNLA, Rystiggo, BOTOX, QULIPTA, Apokyn, VALTOCO.
Industry payments across NJ — which companies pay providers there.
